Tizanidine Tablet
Product Images NDC 68788-7991

5 FDA label images from Preferred Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68788-7991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Hydrochloride Tablet 2mg (Container1)

Tizanidine Hydrochloride Tablet 2mg (Container1)
Tizanidine Hydrochloride Tablet 2 mg package label. The label states the tablet contains 2 mg tizanidine, generic for Zanaflex, manufactured by Dr Reddy's Laboratories Limited. The label includes dosage directions in English and Spanish and cautions about federal law restricting drug transfer. Preferred Pharmaceuticals Inc. is identified at the top.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph displaying plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. It compares four conditions: 2 x 4 mg Tizanidine tablets with food, without food; and 2 x 4 mg Tizanidine capsules with food, without food. The graph shows concentration peaks and decline over 24 hours post-dose.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis represents improvement scores, with higher values indicating greater improvement, and error bars indicate variability at each time point.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A line graph showing improvement in Ashworth Score over time for Tizanidine (mean dose 28.8 mg) versus placebo. The x-axis plots time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis indicates the degree of improvement, with error bars representing variability at each time point.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tizanidine hydrochloride, showing the molecular arrangement of atoms including chlorine, nitrogen, and hydrogen as part of its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.